Cargando…

Challenges in the development of T-cell–based universal influenza vaccines

Detalles Bibliográficos
Autores principales:	Kang, Jung-Ok, Chang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292351/ https://www.ncbi.nlm.nih.gov/pubmed/28168167 http://dx.doi.org/10.7774/cevr.2017.6.1.1

Ejemplares similares

Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020)

Exploring the Potential of T-Cells for a Universal Influenza Vaccine
por: Vijayanand, Sharon, et al.
Publicado: (2020)

Computational Approaches and Challenges to Developing Universal Influenza Vaccines
por: Qiu, Xueting, et al.
Publicado: (2019)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Toward a universal influenza vaccine: from the perspective of protective efficacy
por: Jang, Yo Han, et al.
Publicado: (2013)

Advances in the development of universal influenza vaccines
por: Gilbert, Sarah C.
Publicado: (2012)

Progress in the Development of Universal Influenza Vaccines
por: Sun, Wenqiang, et al.
Publicado: (2020)

Influenza–Host Interplay and Strategies for Universal Vaccine Development
por: Hwang, Hye Suk, et al.
Publicado: (2020)

The challenge of developing universal vaccines
por: Rappuoli, Rino
Publicado: (2011)

Research Updates for Influenza Virus and Vaccine Development
por: Plant, Ewan P., et al.
Publicado: (2021)

Targeting Antigens for Universal Influenza Vaccine Development
por: Nguyen, Quyen-Thi, et al.
Publicado: (2021)

Vaccines for Influenza
por: Tsilibary, Effie-Photini, et al.
Publicado: (2021)

Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus
por: Lee, So-Young, et al.
Publicado: (2019)

Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine
por: Crank, Michelle C, et al.
Publicado: (2019)

Influenza Virus and Vaccination
por: Nogales, Aitor, et al.
Publicado: (2020)

Novel Platforms for the Development of a Universal Influenza Vaccine
por: Kumar, Arun, et al.
Publicado: (2018)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Prospects of HA-Based Universal Influenza Vaccine
por: Hashem, Anwar M.
Publicado: (2015)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?
por: Penttinen, Pasi M, et al.
Publicado: (2016)

Towards universal influenza vaccines?
por: Osterhaus, Ab, et al.
Publicado: (2011)

AVIAN INFLUENZA: REASONS FOR CONCERN AND THE CHALLENGES AHEAD
por: Madani, Tariq A.
Publicado: (2005)

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
por: Wiersma, Lidewij C. M., et al.
Publicado: (2015)

Animal Models for Influenza Viruses: Implications for Universal Vaccine Development
por: Margine, Irina, et al.
Publicado: (2014)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice
por: Mintaev, Ramil R., et al.
Publicado: (2022)

Universal influenza vaccines: Shifting to better vaccines
por: Berlanda Scorza, Francesco, et al.
Publicado: (2016)

English as the universal language of science: opportunities and challenges
por: Drubin, David G., et al.
Publicado: (2012)

Medicines and universal health coverage: challenges and opportunities
por: Bigdeli, Maryam, et al.
Publicado: (2015)

Progress on Seasonal and Pandemic Influenza Vaccines
por: Trombetta, Claudia Maria, et al.
Publicado: (2021)

Efforts to Improve the Seasonal Influenza Vaccine
por: Cianci, Rossella, et al.
Publicado: (2020)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Controlling avian influenza infections: The challenge of the backyard poultry
por: Iqbal, Munir
Publicado: (2009)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Pandemic Influenza Vaccines – The Challenges
por: Haaheim, Lars R., et al.
Publicado: (2009)

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)

Prospects for Universal Influenza Virus Vaccine
por: Gerhard, Walter, et al.
Publicado: (2006)

Biomimetic nanoparticles as universal influenza vaccine
por: Wang, Fengyuan, et al.
Publicado: (2020)

Is a universal influenza vaccine feasible?
por: Phillipson, Joshua E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_na18cbk26ja10hag9v5emtfd4n